Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
Author:
Affiliation:
1. China‐Japan Union HospitalJilin University Changchun China
2. The First Hospital of Jilin University Changchun China
3. The Basic Medical College of Jilin University Changchun China
Funder
People's Government of Jilin Province
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17147
Reference52 articles.
1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
3. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
5. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Small-molecule Molephantin induces apoptosis and mitophagy flux blockage through ROS production in glioblastoma;Cancer Letters;2024-06
2. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis;Journal of Translational Medicine;2024-05-03
3. Cancer resistance and metastasis are maintained through oxidative phosphorylation;Cancer Letters;2024-04
4. Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma;Mitochondrion;2024-03
5. Mitochondrial response of glioma cells to temozolomide;Experimental Cell Research;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3